Literature DB >> 24783645

[Surgical treatment of giant congenital melanocytic nevi: a change of aim].

J Carrera, A Albert, F J Parri, M A Vicente, D Brualla, C Rovira, M L Manzano.   

Abstract

OBJECTIVE: To review the surgical experience in Giant Congenital Melanocytic Nevi (GCMN).
MATERIAL AND METHODS: Review of GCMN cases consulting at the Department of Pediatric Surgery since 1994. Data registered were: year and age at 1st consultation, type of treatment, number of surgical procedures and complications, histology, central nervous system MRI and follow-up.
RESULTS: Eleven patients with GCMN > 10% of body surface consulted at ages ranging from newborn to 8 years. All of them had multiple surgical procedures (2-19), from nevus removal to only biopsies. Eight patients had tissue expansion, completed in 3 of them with skin grafts on dermal substitute. Six patients had complications: 4 expander extrusions, 5 infections, 3 flap necrosis and 1 dehiscence. In 6 children a total or subtotal resection of the nevus was achieved; in 2 the treatment was interrupted, remaining 20% and 50% of the initial nevus; three patients had not had nevus treatment. None of the patients presented cutaneous melanoma; one died from intracranial melanoma; another one has leptomeningeal melanosis. The first 4 patients underwent an average of 16 surgical procedures each, the last 7 patients only 5.
CONCLUSIONS: The aim of GCNM management has changed: GCNM treatment is now surgically conservative. Complete excision is now not the aim when technically unfeasible in few procedures; multiple surgical procedures with poor cosmetical results are not acceptable. The gravity is determined by CNS involvement.

Entities:  

Mesh:

Year:  2014        PMID: 24783645

Source DB:  PubMed          Journal:  Cir Pediatr        ISSN: 0214-1221


  1 in total

1.  An alternative strategy treated giant congenital melanocytic nevi with epidermis and superficial dermis of the lesions.

Authors:  Chuan Gu; Xiu-Xia Wang; Xusong Luo; Fei Liu; Xian-Yu Zhou; Jun Yang; Qun Yang; Xi Wang
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.